SES · BSL.SI
Raffles Medical Group Ltd
SGD 0.82+SGD 0.01 (+0.61%)
Raffles Medical Group Ltd’s quoted price sits in the lower half of its reported 52-week range, 24.07% below the high.
Loading market information…
SES · QC7.SI · SGD
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 09:09 AM UTC. Cached market data; not a live quote.
One-year closing-price history · SGD. Historical prices are not a forecast.
Q & M Dental Group (Singapore) Limited’s quoted price sits in the lower half of its reported 52-week range, 22.83% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Q & M Dental Group (Singapore) Limited’s forward annual dividend is SGD 0.01 per share, paid semi-annual. The forward yield is 1.63% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Q & M Dental Group (Singapore) Limited’s next earnings report is currently expected on Mar 1, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Q & M Dental Group (Singapore) Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Q & M Dental Group (Singapore) Limited, an investment holding firm, primarily delivers private dental healthcare services. The company's operations are divided into three main segments: Primary Healthcare, Dental Equipment and Supplies Distribution, and Medical Laboratory. It offers a comprehensive spectrum of dental services, encompassing general dentistry, aesthetic and cosmetic treatments, CAD CAM digital solutions, pediatric and geriatric dental care, and dental implants. Specific procedures include consultations, gum disease treatment and surgery, oral surgery, root canal therapy, scaling and polishing, teeth grinding solutions, whitening procedures, tooth-colored fillings, wisdom tooth extractions, crowns and bridges, dental X-rays, dentures, extractions, mouth guards, orthodontics, and sensitive teeth care. Beyond its dental offerings, the group provides extensive general health services. These comprise adult and children consultations, chronic disease management, men's health, and skin care services. Preventative care includes cervical PAP smears, family planning, general and pre-marital health screenings, smoking cessation programs, and weight loss management. Vaccinations for conditions such as cervical cancer, chickenpox, childhood diseases, hepatitis, and influenza are available, along with travel health advice. Additional services extend to pre-education/extracurricular activity certifications, pre-employment checks, ear syringing, removal of foreign materials and warts, suturing, and wound care and dressing. The company further engages in swabbing, pre-departure and pre-event testing, and general laboratory testing services, as well as selling test kits. It also contributes to professional development by offering higher education programs for dentists, trades in dental surgery materials and equipment, and develops dental healthcare software and specialized equipment. As of December 31, 2021, Q & M Dental Group operated a significant network, including 97 dental clinics, 5 medical clinics, and 1 dental college in Singapore. Its international footprint extended to 38 dental clinics in Malaysia and one dental clinic in the People's Republic of China. Founded in 1996, the company is headquartered in Singapore and functions as a subsidiary of Quan Min Holdings Pte. Ltd.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:01 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| SGD 44.40M |
| Q4 2023 | Feb 29, 2024 | SGD 0.00 | SGD 95.60M-49.3% vs estimate |
|---|
Latest available per-share figures in SGD. The payout ratio compares dividends with earnings.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
SGD 0.82+SGD 0.01 (+0.61%)
Raffles Medical Group Ltd’s quoted price sits in the lower half of its reported 52-week range, 24.07% below the high.
SGD 0.51+SGD 0.01 (+2.0%)
iX Biopharma Ltd.’s quoted price sits in the upper half of its reported 52-week range, 18.4% below the high.
SGD 0.34SGD 0.00 (0.0%)
HC Surgical Specialists Limited’s quoted price sits in the lower half of its reported 52-week range, 15.0% below the high.
SGD 0.08-SGD 0.00 (-1.32%)
UG Healthcare Corporation Limited’s quoted price sits in the lower half of its reported 52-week range, 31.82% below the high.
SGD 0.02+SGD 0.00 (+15.0%)
Singapore Institute of Advanced Medicine Holdings Ltd.’s quoted price sits in the lower half of its reported 52-week range, 74.16% below the high.
SGD 0.07SGD 0.00 (0.0%)
Vicplas International Ltd’s quoted price sits in the lower half of its reported 52-week range, 35.64% below the high.
SGD 0.23SGD 0.00 (0.0%)
Niks Professional Ltd’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
SGD 0.20SGD 0.00 (0.0%)
Medinex Limited’s quoted price sits in the lower half of its reported 52-week range, 21.57% below the high.
